Alphabet insider trade: 2,778 Class C shares sold under 10b5-1 plan
Rhea-AI Filing Summary
Amie Thuener O'Toole, Vice President and Chief Accounting Officer of Alphabet Inc., reported transactions on a Form 4 dated 09/15/2025 showing an insider sale and related equity unit activity. The filing discloses a sale of 2,778 shares of Alphabet Class C capital stock at a weighted average price of $245 per share (sales ranged $245–$246). The report also shows the acquisition of 14 dividend equivalent units (DEUs) tied to Class C Google Stock Units at no cash price and lists beneficial ownership following the transactions as 17,293 Class C shares, 16,303 and 16,844 Class C GSUs (per separate grant lines), and 8,940 Class A common shares. The filing notes the DEUs vest on the same schedule as the underlying GSUs and that the reported transactions were effected under a Rule 10b5-1 trading plan adopted May 23, 2025.
Positive
- Transaction executed under a Rule 10b5-1 plan, indicating pre-established trading arrangements and procedural compliance
- Detailed vesting schedule disclosed for GSUs and DEUs, clarifying future equity vesting timing
Negative
- Insider sale of 2,778 Class C shares at a weighted average price of $245, representing disposition of stock holdings
Insights
TL;DR: Modest insider sale with continuing equity-based compensation; transaction executed under a pre-established 10b5-1 plan.
The sale of 2,778 Class C shares at a weighted average price of $245 is explicitly disclosed and represents a partial disposition rather than a full exit from company equity, given the reported retained holdings (17,293 Class C and substantial GSUs). The filing also documents 14 DEUs credited at $0 that will vest with underlying GSUs, preserving future equity exposure tied to continued employment. Because the transaction was effected under a Rule 10b5-1 plan adopted May 23, 2025, the timing is governed by that plan rather than an ad hoc insider trade. For investors, this filing documents routine insider liquidity and ongoing compensation vesting schedules; it does not by itself provide operating or financial performance information.
TL;DR: Disclosure follows standard Section 16 reporting and cites a 10b5-1 plan, indicating procedural compliance.
The Form 4 shows required Section 16 disclosure: identity and role of the reporting person, specific share sale quantities and prices (weighted average $245, range $245–$246), grant-related DEUs, vesting schedules, and a signature by an attorney-in-fact. Notably, the filing explicitly states the 10b5-1 plan adoption date (May 23, 2025), which supports a claim that the sale was pre-planned and compliant with insider trading rules. The record provides clear vesting timelines for GSUs and DEUs but contains multiple GSU lines that should be interpreted as separate grants per the filer’s notes.